---
brand_name: "NEORAL"
generic_name: "CYCLOSPORINE"
slug: "cyclosporine-ued-or-withdrawn-f"
canonical_url: "https://medichelpline.com/drug-index/cyclosporine-ued-or-withdrawn-f"
content_type: "drug_monograph"
route: "ORAL"
drug_class: "General Medications"
fda_updated_at: "2023-09-26T00:00:00.000Z"
license: "Drugs@FDA Public Domain / Informational Use"
---
# NEORAL (CYCLOSPORINE)
## Clinical Monograph Metadata
- **Canonical URL:** https://medichelpline.com/drug-index/cyclosporine-ued-or-withdrawn-f
- **Generic / Active Ingredient:** CYCLOSPORINE
- **Brand Name:** NEORAL
- **Administration Route:** ORAL
- **Pharmacological Class:** General Medications
- **FDA Data Timestamp:** 2023-09-26T00:00:00.000Z
## Primary Indication & Clinical Use
Review priority: STANDARD Marketing status: Discontinued
## Monograph Summary

Approval overview NEORAL is listed in Drugs@FDA under application 050715 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLOSPORINE Form and strength CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2023-09-26 00:00:00. Submission type: SUPPL.

## Primary Sources & FDA Regulatory Records
- [Drugs@FDA Primary Database](https://www.accessdata.fda.gov/scripts/cder/daf/) (Reference Slug: `cyclosporine-ued-or-withdrawn-f`)
## Navigation
- [← Back to Drug Index Hub](https://medichelpline.com/drug-index.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.